Clinical Trial Update: Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation [Phase 3]

View source ↗

Summary

Phase 3 trial update on zoledronate for preventing bone loss in men with prostate cancer on long-term androgen deprivation; study terminated with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Prostate Cancer

Drugs mentioned

• Zoledronate (zoledronic acid)

Snippet

Sponsor: Northwestern University | Conditions: Osteoporosis, Prostate Cancer | Phase 3 | Status: TERMINATED | Results posted: 2020-11-19